ClinicalTrials.Veeva

Menu

Intraoperative OCT Guidance of Intraocular Surgery II (MIOCT)

Duke University logo

Duke University

Status

Enrolling

Conditions

Preretinal Fibrosis
Healthy
Retinal Detachment
Strabismus
Cataract
Ocular Tumor
Retinal Disease
Macular Holes
Epiretinal Membrane
Diabetic Retinopathy

Treatments

Device: Microscope integrated optical coherence tomography

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT03713268
Pro00100437
U01EY028079 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The overall five-year goals of the project are to develop novel technology to provide actionable new information through provision of live volumetric imaging during surgery, improving surgical practice and outcomes. The investigators believe this technology will enable novel ophthalmic and other microsurgeries not possible due to current limitations in surgical visualization.

Enrollment

262 estimated patients

Sex

All

Ages

4+ weeks old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Healthy controls: Healthy eyes without known disease: refractive error including myopia and non-significant cataract is allowed. For selected testing pseudophakia is allowed.
  2. Surgeons as research subjects: Adult (≥18 years old)
  3. Surgical patients (vitreoretinal surgery): Patients undergoing examination under anesthesia or surgery for vitreoretinal diseases
  4. Surgical patients (anterior segment surgery-glaucoma, ocular surface or strabismus requiring extraocular muscle surgery): Include both adults and children. Patient undergoing primary, elective minimally invasive glaucoma surgery, ocular surface surgery, or strabismus surgery.

Exclusion criteria

  1. Healthy controls: Any ocular disease that restricts the ability to perform OCT scanning. Conflict of interest with investigators/study personnel, e.g. a student in the lab of an investigator.
  2. Surgeons as research subjects: no specific exclusion criteria.
  3. Surgical patients (vitreoretinal surgery): Neonates (< 4 weeks of age) and patients with any ocular disease that restricts the ability to perform OCT scanning.
  4. Surgical patients (anterior segment surgery-corneal and cataract diseases): Pediatric patients: The cornea and cataract surgery studies will be restricted to adults (≥ 18 years). Children do not have cataract surgery typically by residents and therefore would not fit our study design. Similarly pediatric corneal transplants are very rare.

Trial design

262 participants in 3 patient groups

Healthy (ocular health) participants
Description:
Adult subjects with normal, ocular health will be enrolled to evaluate and obtain multiple images from the microscope integrated optical coherence tomography system for reproducibility testing in humans, provide feedback to engineers, and verify that the system functions to produce high quality images of the desired areas of the eye after ex vivo development before surgical use. Each healthy subject will be imaged by the MIOCT system. There will be no surgery or intervention on these healthy volunteer subjects. We anticipate that a portion of the volunteer subjects would have repeat imaging (e.g. for reproducibility testing).
Treatment:
Device: Microscope integrated optical coherence tomography
Surgeons as research subjects
Description:
Duke Eye Center surgical trainees (residents and fellows), attending surgeons, and surgeons from other medical institutions will be enrolled as subjects as we will test their performance with and without microscope integrated optical coherence tomography and with and without advances in 4D MIOCT in model surgeries in the research wet lab to better understand the utility of specific aspects and of this next generation MIOCT as a whole for specific anterior segment and retinal surgical tasks.
Treatment:
Device: Microscope integrated optical coherence tomography
Surgical patients
Description:
Adult and minor (\> 4 months of age) surgical patients will be enrolled to evaluate and obtain multiple images from the microscope integrated optical coherence tomography system during clinically indicated vitreoretinal and anterior segment surgical procedures.
Treatment:
Device: Microscope integrated optical coherence tomography

Trial contacts and locations

1

Loading...

Central trial contact

Neeru Sarin, MBBS; Michelle N McCall, MCAPM, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems